Related Experiment Video
Updated: Aug 10, 2025

06:49
Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
2.0K
Fundamentals of Bowel Cancer for Biomedical Engineers
Jiyuan Tian1, Kenneth Omokhagbo Afebu1, Andrew Bickerdike1
1Engineering Department, University of Exeter, North Park Road, Exeter, EX4 4QF, UK.
Annals of Biomedical Engineering
|February 14, 2023
Summary
Early detection of bowel cancer is crucial for reducing mortality. This review explores bowel cancer origins, metastasis, biomechanics, and current diagnostic methods, highlighting the potential of medical robotics for earlier diagnosis.
Area of Science:
- Gastroenterology
- Oncology
- Biomedical Engineering
Background:
- Bowel cancer is a complex disease influenced by genetics and environment.
- Current diagnostic methods like endoscopy and imaging often fail to detect early-stage, small, or flat lesions.
- Late diagnosis increases the risk of metastasis and cancer death.
Purpose of the Study:
- To summarize the origins and metastatic mechanisms of bowel cancer.
- To review the biomechanics and measurement techniques relevant to developing new diagnostic devices.
- To assess current diagnostic techniques and identify clinical needs for early detection.
Main Methods:
- Literature review of bowel cancer origins, metastasis, and biomechanics.
- Analysis of existing bowel cancer diagnostic techniques.
- Exploration of medical robotics applications in early diagnosis.
Main Results:
- Bowel cancer arises from genetic and environmental factors, with metastasis being a key driver of mortality.
- Existing diagnostic tools have limitations in detecting early-stage lesions.
- Biomechanics and measurement techniques are critical for novel diagnostic device development.
Conclusions:
- Early detection and removal of bowel cancer lesions significantly reduce mortality.
- There is a need for improved diagnostic tools to detect early-stage bowel cancer.
- Medical robotics show promise for enhancing early bowel cancer diagnosis and patient outcomes.

